ICRISAT Public Disclosure Cytoplasmic male sterile gene orf147 of pigeonpea, and uses thereof

Under the policy, as a general rule, such applications will not be made unless they are necessary for the further improvement of the Intellectual Assets or to enhance the scale or scope of impact on target beneficiaries, in furtherance of the CGIAR Vision. [...] The protected technology is a process patent where a method of obtaining a male sterile plant harboring in its genome a DNA construct, that is synthetic in nature and is assembled in a specific manner to achieve the desired outcome (in this case, male sterility which is a universal component of hybrid systems across crops). [...] 3 Dissemination strategy ICRISAT will implement a responsible dissemination strategy with all partners in the countries where the technology will be used for further development and deployment with due consideration to the appropriate legal and hybrid seed production systems in the target crops and geographies to ensure further technological improvements with a commitment that the smallholder farm. [...] Pathway of the innovation to market and to smallholder farmers The dissemination strategy for this platform technology for the benefit of public research institutions and NARS has been indicated above. [...] The knowhow and the gene(s) constructs shall be made available to NARS and other public research organizations for use in a range of crops under appropriate Material Transfer Agreements in a non-exclusive manner for the benefit of smallholder farmers.